Mirror molecules — synthesized chemical inverse images of natural counterparts — have potential as drugs for hard-to-treat diseases. But extending such work to create entire mirror organisms could pose serious biosafety risks. One researcher who studies mirror-image peptides considers where to draw the line.
↧
